TY  - GEN
AU  - Bensink,Mark
AU  - Edwards,Christine
AU  - Bowers,Charles
AU  - Campbell,Jon
TI  - Response to: McBride A, Campbell K, Bikkina M, et al. Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia. J Med Econ 2017;20:1083-93
SN  - 1941-837X
PY  - 2019///0830
KW  - Antineoplastic Agents
KW  - Biosimilar Pharmaceuticals
KW  - Filgrastim
KW  - Humans
KW  - Polyethylene Glycols
N1  - Publication Type: Journal Article; Comment
UR  - https://doi.org/10.1080/13696998.2018.1452747
ER  -